163 related articles for article (PubMed ID: 27250990)
1. Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer.
Kato Y; Takahashi S; Gotohda N; Konishi M
J Gastrointest Surg; 2016 Aug; 20(8):1435-43. PubMed ID: 27250990
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer.
Yamashita S; Passot G; Aloia TA; Chun YS; Javle M; Lee JE; Vauthey JN; Conrad C
Br J Surg; 2017 Feb; 104(3):267-277. PubMed ID: 28052308
[TBL] [Abstract][Full Text] [Related]
3. Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma.
Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Sasaki H; Sueda T
J Surg Oncol; 2014 Sep; 110(4):422-9. PubMed ID: 24889968
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of preoperative CA19-9 and lymph node metastasis in intrahepatic cholangiocarcinoma.
Asaoka T; Kobayashi S; Hanaki T; Iwagami Y; Tomimaru Y; Akita H; Noda T; Gotoh K; Takeda Y; Tanemura M; Doki Y; Eguchi H
Surg Today; 2020 Oct; 50(10):1176-1186. PubMed ID: 32221659
[TBL] [Abstract][Full Text] [Related]
5. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
[TBL] [Abstract][Full Text] [Related]
6. Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.
Cai WK; Lin JJ; He GH; Wang H; Lu JH; Yang GS
Int J Clin Exp Pathol; 2014; 7(11):7890-8. PubMed ID: 25550829
[TBL] [Abstract][Full Text] [Related]
7. Predictors of postoperative early recurrence of extrahepatic bile duct cancer.
Akita M; Ajiki T; Ueno K; Tsugawa D; Hashimoto Y; Tanaka M; Kido M; Toyama H; Fukumoto T
Surg Today; 2020 Apr; 50(4):344-351. PubMed ID: 31549244
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer.
Song DH; Cho IK; Shin DW; Lee JC; Cho JY; Yoon YS; Hwang JH; Han HS; Kim J
Surg Today; 2021 Jun; 51(6):978-985. PubMed ID: 33387024
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Cholangitis Affects Survival Outcome in Patients with Extrahepatic Bile Duct Cancer.
Akita M; Ajiki T; Matsumoto T; Shinozaki K; Goto T; Asari S; Toyama H; Kido M; Fukumoto T; Ku Y
J Gastrointest Surg; 2017 Jun; 21(6):983-989. PubMed ID: 28290140
[TBL] [Abstract][Full Text] [Related]
10. Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value.
Yamamoto Y; Sugiura T; Todaka A; Okamura Y; Ito T; Ashida R; Kakuda Y; Nakanuma Y; Uesaka K
World J Surg; 2018 Oct; 42(10):3331-3340. PubMed ID: 29619514
[TBL] [Abstract][Full Text] [Related]
11. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
[TBL] [Abstract][Full Text] [Related]
12. Preoperative C-reactive protein-to-albumin ratio predicts long-term outcomes in extrahepatic cholangiocarcinoma patients.
Yasukawa K; Shimizu A; Motoyama H; Kubota K; Notake T; Fukushima K; Ikehara T; Hayashi H; Kobayashi A; Soejima Y
J Surg Oncol; 2020 Nov; 122(6):1094-1105. PubMed ID: 32634266
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Soluble Intercellular Adhesion Molecule-1 and Interleukin-6 in Patients with Extrahepatic Cholangiocarcinoma.
Shimura T; Shibata M; Gonda K; Kofunato Y; Okada R; Ishigame T; Kimura T; Kenjo A; Marubashi S; Kono K; Takenoshita S
J Invest Surg; 2018 Dec; 31(6):475-482. PubMed ID: 28925763
[TBL] [Abstract][Full Text] [Related]
14. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.
Sasaki R; Takeda Y; Funato O; Nitta H; Kawamura H; Uesugi N; Sugai T; Wakabayashi G; Ohkohchi N
World J Surg; 2007 Sep; 31(9):1788-1796. PubMed ID: 17647056
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
[TBL] [Abstract][Full Text] [Related]
16. Novel staging system using carbohydrate antigen (CA) 19-9 in extra-hepatic cholangiocarcinoma and its implications on overall survival.
Tella SH; Kommalapati A; Yadav S; Bergquist JR; Goyal G; Durgin L; Borad M; Cleary SP; Truty MJ; Mahipal A
Eur J Surg Oncol; 2020 May; 46(5):789-795. PubMed ID: 31954549
[TBL] [Abstract][Full Text] [Related]
17. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma.
Akita M; Ajiki T; Ueno K; Tsugawa D; Tanaka M; Kido M; Toyama H; Fukumoto T
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):147-152. PubMed ID: 32037277
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic cholangiocarcinoma: a clinicopathologic study of 37 resected cases.
Zhu HF; Li J; Huang L; Yan YQ
Hepatogastroenterology; 2013; 60(122):263-7. PubMed ID: 23574653
[TBL] [Abstract][Full Text] [Related]
19. Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: a meta-analysis.
Liu SL; Song ZF; Hu QG; Shan D; Hu SB; Li J; Zheng QC
Front Med China; 2010 Dec; 4(4):457-62. PubMed ID: 21191748
[TBL] [Abstract][Full Text] [Related]
20. Double-Negative α-Fetoprotein and Carbohydrate Antigen 19-9 Predict a Good Prognosis in Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis.
Zhang X; Zhou Y; Wu Z; Peng W; Li C; Yan L; Yang J; Wen T
Clin Transl Gastroenterol; 2021 Nov; 12(11):e00425. PubMed ID: 34751187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]